Inventor
HUSSAIN ANWAR A
30 patents
⚠️ This page may combine multiple inventors who share the name “HUSSAIN ANWAR A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV KENTUCKY RES FOUND
8 patentsUS4464378AAug 7, 1984
Method of administering narcotic antagonists and analgesics and novel dosage forms containing same
UNIV KENTUCKY RES FOUND389 citations99
US4383993AMay 17, 1983
Nasal dosage forms containing natural female sex hormones
UNIV KENTUCKY RES FOUND99 citations94
US4315925AFeb 16, 1982
Method of administering natural female sex hormones
UNIV KENTUCKY RES FOUND84 citations94
US4885287ADec 5, 1989
Novel method of administering aspirin and dosage forms containing same
UNIV KENTUCKY RES FOUND49 citations90
US4394390AJul 19, 1983
Nasal dosage forms of propranol
UNIV KENTUCKY RES FOUND20 citations81
US4428883AJan 31, 1984
Novel method of administering β-blockers and novel dosage forms containing same
UNIV KENTUCKY RES FOUND16 citations74
US4284648AAug 18, 1981
Nasal administration of propranolol
UNIV KENTUCKY RES FOUND13 citations72
US5985239ANov 16, 1999
Derivatives of N-chloro-N-methyl glucamine and N-chloro-N-methyl glucamine esters
UNIV KENTUCKY RES FOUND12 citations70
ALZA CORP
6 patentsUS3960150AJun 1, 1976
Bioerodible ocular device
ALZA CORP199 citations99
US3995635ADec 7, 1976
Ocular insert
ALZA CORP159 citations97
US3993071ANov 23, 1976
Bioerodible ocular device
ALZA CORP118 citations96
US3986510AOct 19, 1976
Bioerodible ocular device
ALZA CORP142 citations96
US4188951AFeb 19, 1980
Intrauterine system embracing selected copolymeric membranes for administering beneficial agent
ALZA CORP39 citations93
US3981303ASep 21, 1976
Bioerodible ocular device
ALZA CORP51 citations92
INTERX RESEARCH CORP
6 patentsUS4035507AJul 12, 1977
Novel, transient pro-drug forms of L-DOPA to treat Parkinson's disease
INTERX RESEARCH CORP130 citations96
US3998799ADec 21, 1976
Novel, transient pro-drug forms of l-dopa
INTERX RESEARCH CORP99 citations96
US3939253AFeb 17, 1976
Novel, transient pro-drug forms of l-dopa useful in the treatment of parkinson's disease
INTERX RESEARCH CORP114 citations96
US4065566ADec 27, 1977
N-Nicotinoyl-3,4-dinicotinoyloxy-L-phenylalanine and derivatives pharmaceutical compositions and methods containing same
INTERX RESEARCH CORP19 citations82
US4120958AOct 17, 1978
Novel 2-acetoxybenzoic acid-nicotinamide complexes
INTERX RESEARCH CORP3 citations63
US3956490AMay 11, 1976
Administration of alkaline earth metal salts of salicylamide
INTERX RESEARCH CORP4 citations63
NEW MILLENNIUM PHARMACEUTICAL
3 patentsUS6608073B1Aug 19, 2003
Intranasal codeine for the rapid suppression of cough and rapid relief of pain
NEW MILLENNIUM PHARMACEUTICAL184 citations96
US6369058B1Apr 9, 2002
Brain delivery of folic acid for the prevention of alzheimer's disease and stroke
NEW MILLENNIUM PHARMACEUTICAL19 citations90
US6380175B1Apr 30, 2002
Method for enhancement of delivery of THC by the administration of its prodrugs via the nasal route
NEW MILLENNIUM PHARMACEUTICAL18 citations87
UNIV KENTUCKY
3 patentsUS5424402AJun 13, 1995
Non-destructive method for radiolabelling biomolecules by halogenation
UNIV KENTUCKY7 citations73
US6423701B1Jul 23, 2002
Water soluble amine esters of testosterone for intranasal administration
UNIV KENTUCKY5 citations63
US5753701AMay 19, 1998
N-chloro-N-methyl glucamine and N-chloro-N-methyl glucamine esters as novel safe agents for water disinfection
UNIV KENTUCKY1 citations59